Elsevier

The Lancet

Volume 332, Issue 8618, 29 October 1988, Pages 986-989
The Lancet

LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR

https://doi.org/10.1016/S0140-6736(88)90742-8Get rights and content

Abstract

In vitro the mineralocorticoid receptor is non-specific and does not distinguish between aldosterone and cortisol. In vivo certain tissues with this receptor are aldosterone selective (eg, kidney and parotid) whereas others with the same receptor are not (eg, hippocampus and heart). Experiments in rats showed that 11β-hydroxysteroid dehydrogenase (which converts cortisol to cortisone in man and corticosterone to 11-dehydrocorticosterone in the rat) was much more highly concentrated in aldosterone-selective tissues than in non-selective tissues. The localisation in the selective tissues was such that the enzyme could act as a paracrine or possibly an autocrine mechanism protecting the receptor from exposure to corticosterone. Autoradiographic studies showed that protection is lost when the enzyme is inhibited; 3H-corticosterone and 3H-aldosterone were bound to similar sites. These findings seem to explain why sodium retention, hypokalaemia, and hypertension develop in subjects with congenital deficiency of 11β-OHSD and those in whom the enzyme has been inhibited by liquorice.

References (31)

  • Crw Edwards et al.

    Cushing's disease of the kidney

    J Endocrinol

    (1985)
  • Pm Stewart et al.

    The syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle

    J Clin Invest

    (1988)
  • Se Oberfield et al.

    Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess

    J Clin Endocrinol Metab

    (1983)
  • H. Rasmussen

    Isolated mammalian renal tubules

  • Dw Scholer et al.

    Isolation of rat kidney cortical tubules enriched in proximal and distal segments

    Am J Physiol

    (1979)
  • Cited by (1054)

    • Clinical diagnosis and treatment of apparent mineralocorticoid excess

      2023, Genetic Steroid Disorders: Second Edition
    • Classic endocrine disorders: implications for cardiovascular disease

      2023, Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine
    View all citing articles on Scopus
    View full text